Skip to content

Advertisement

Articles

Page 5 of 6

  1. Content type: Research article

    To evaluate the determinants of compliance with national policies recommending Artemisinin Combination Therapy (ACT) for the treatment of uncomplicated malaria in the community.

    Authors: Catherine E Vialle-Valentin, Robert F LeCates, Fang Zhang and Dennis Ross-Degnan

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:1

    Published on:

  2. Content type: Oral presentation

    Authors: Matthew Ziba, Joseph Babigumira, Jessica Crawford, John Kandaya, Charles Chimenya, Alisa Jenny, Solomon Lubinga, Charles Matemba, Erin Larsen-Cooper and Andy Stergachis

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O23

    Published on:

    This article is part of a Supplement: Volume 7 Supplement 1

  3. Content type: Poster presentation

    Authors: Greatjoy Njabulo Mazibuko, Evans Sagwa, Harriet Rachel Kagoya, Dan Kibuule, Timothy Rennie, Tukai Mavere, Reem Ghoneim, David Mabirizi, Ester Naikaku, Qamar Niaz and Jennie Lates

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P12

    Published on:

    This article is part of a Supplement: Volume 7 Supplement 1

  4. Content type: Poster presentation

    Authors: Alexis Heaton, Amanda Ombeva, Deogratias Leopold, Golbert Kazoza, Patrick Nganji, Cathy Mugeni, Megan Noel and Yasmin Chandani

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P11

    Published on:

    This article is part of a Supplement: Volume 7 Supplement 1

  5. Content type: Research article

    This study aimed to explore patients’ utilization of repeat prescriptions for antibiotics indicated in upper respiratory tract infections (URTI). An emphasis was placed on whether the current system of repeat ...

    Authors: Iman Zayegh, Theresa L Charrois, Jeffery Hughes and Kreshnik Hoti

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:17

    Published on:

  6. Content type: Research article

    Many low income countries struggle to provide safe and effective medicines due to poor public health care infrastructure, budgetary constraints, and lack of human resource capacity. Private sector pharmacies a...

    Authors: Catherine Birabwa, Jude Murison, Valerie Evans, Celestino Obua, Amon Agaba, Paul Waako and Allyson Pollock

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:18

    Published on:

  7. Content type: Commentary

    Death among tuberculosis patients is one of the major reasons for non-attainment of 85% treatment success target set by World Health Organization. In this short paper, we evaluated whether the overall mortalit...

    Authors: Muhammad Atif, Syed Azhar Syed Sulaiman, Asrul Akmal Shafie, Muhammad Qamar Uz Zaman and Muhammad Asif

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:16

    Published on:

  8. Content type: Research

    Adherence to treatment guidelines for uncomplicated malaria is critical to the success of malaria case management. Poor adherence has implications for increased malaria burden, in view of the risk of widesprea...

    Authors: Charles C Ezenduka, Mathew J Okonta and Charles O Esimone

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:15

    Published on:

  9. Content type: Research

    To determine the incidence of symptomatic moderate-to-severe adverse events during treatment of drug-resistant tuberculosis, and to compare their risk and outcomes by patients’ human immunodeficiency virus (HI...

    Authors: Evans L Sagwa, Aukje K Mantel-Teeuwisse and Nunurai C Ruswa

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:14

    Published on:

  10. Content type: Research

    The United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), the main primary healthcare provider for 4.9 million Palestinian refugees, spent USD18.3 million on essential medicin...

    Authors: Margaret Ewen, Maisa Al Sakit, Rawan Saadeh, Richard Laing, Catherine Vialle-Valentin, Akihiro Seita and Joske Bunders

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:13

    Published on:

Annual Journal Metrics

Advertisement